Question
Which baseline factor is associated with improved PFS and OS in patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation who receive dabrafenib plus trametinib?
and select "Add to Home
screen" to pin the M3 India App to your Home screen
